IOBT FY 2023 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$756,000

Operating Income

-$91M

Net Income

-$86M

EPS (Diluted)

$-1.98

Cash Flow

Operating Cash Flow

-$72M

Free Cash Flow

-$72M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$151M

Total Liabilities

$18M

Stockholders' Equity

$133M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$756,000	-$540,000	-40.0%
Operating Income	-$91M	-$71M	-28.0%
Net Income	-$86M	-$71M	-20.5%